Yakeb to discuss treatment plan for ailing Saravanan with UMMC
Yakeb chairman Datuk Ahmad Shapawi Ismail said the foundation is set to discuss a treatment plan for him with University Malaya Medical Centre (UMMC), where Saravanan has been receiving treatment on a scheduled basis.
Saravanan is a legendary Malaysian athlete who won gold in race walking at the 1998 Kuala Lumpur Commonwealth Games. No other Malaysian track and field athlete has been able to win gold at the Commonwealth Games since then.
"The disease Saravanan has is quite critical and treatment for it is hard to explain," said Shapawi in a press conference here today (April 22).
"I have discussed this with Yakeb board member Dr. Ahmad Munawwar Helmi Salim, who is also director of sports medicine at the National Sports Institute.
"We will have a discussion with UMMC soon to look at the most efficient way to treat him and get a better picture of how we can best help him.
"Saravanan (who was warded at UMMC recently) has returned to Penang but will later return to Kuala Lumpur for his next scheduled appointment with UMMC."
Despite facing financial constraints themselves, Shapawi said Yakeb has done their best to assist Saravanan since he was diagnosed with MND in 2021.
This includes helping him obtain employment with the Penang State Sports Council in 2023, obtain invalidity pension from the Social Security Organisation last year as well as help support costs for him to obtain alternative treatment in India (2024-2025).
Yakeb is also providing Saravanan with a subsistence allowance for a period of six months, beginning from this month.
MND is a debilitating, life-shortening disease which causes muscle weaknesses that becomes progressively worse with time. It is the same disease that the late Datuk Mokhtar Dahari faced.
There is currently no cure for the disease though treatment is available to manage symptoms and improve quality of life.
Saravanan has received extra support since his plight made headlines last week.
Prime Minister Datuk Seri Anwar Ibrahim contributed RM10,000 while public donations have exceeded RM20,000.
Saravanan's treatment costs in excess of RM1,000 per week and his family have spent more than RM100,000 on treatment since 2021.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
Yakeb to aid motorcross rider Gabit for cancer treatment
Yakeb chairman Datuk Ahmad Shapawi Ismail, together with former athletes during the 'Prihatin Sukan, Untukmu Jaguh' programme. KUALA LUMPUR: National motocross rider Mohd Habibullah Mohd Saleh, known as Gabit, can breathe a sigh of relief after receiving assistance from the National Athletes Welfare Foundation (Yakeb) for his nasal cancer treatment. Yakeb chairman Datuk Ahmad Shapawi Ismail said the decision was made following an unanimous agreement of the foundation's board members to approve the eligibility criteria for motorsports athletes. "He (Gabit) is currently undergoing follow up treatment, and we will also help facilitate the appropriate assistance for his treatment. "If he receives treatment at a government hospital, the treatment costs will be covered by Yakeb, and we will also provide other incentives," he said. He was speaking to reporters after the 'Prihatin Sukan, Untukmu Jaguh' programme, organised by the Faculty of Sports Science and Recreation at Universiti Teknologi Mara on Friday (July 4). . It was earlier reported that Gabit was in the process of becoming a Yakeb member but faced several issues in submitting the necessary documentation. He was diagnosed with stage four cancer in 2021, and after undergoing chemotherapy treatment, the 34-year-old former rider was declared cancer-free in 2023. Currently, he has completed 18 chemotherapy sessions at the National Cancer Institute (IKN), which were self-funded. - Bernama
The Sun
2 hours ago
- The Sun
Yakeb supports motocross rider Gabit with cancer treatment aid
NATIONAL motocross rider Muhamad Habibullah Mohd Saleh, popularly known as Gabit, has received much-needed support from the National Athletes Welfare Foundation (Yakeb) for his nasal cancer treatment. The aid comes as a relief for the athlete, who has been battling the disease since 2021. Yakeb Chairman Datuk Ahmad Shapawi Ismail confirmed the assistance, stating that the foundation's board members unanimously approved the eligibility criteria for motorsports athletes. 'He is currently undergoing follow-up treatment, and we will facilitate appropriate assistance. If treated at a government hospital, Yakeb will cover the costs and provide additional incentives,' he said. Ahmad Shapawi spoke after the 'Prihatin Sukan, Untukmu Jaguh' programme organised by Universiti Teknologi MARA's Faculty of Sports Science and Recreation. Earlier reports highlighted Gabit's struggle to complete his Yakeb membership due to documentation issues. Gabit was diagnosed with stage four cancer in 2021. After undergoing chemotherapy, the 34-year-old was declared cancer-free in 2023. However, he has since completed 18 self-funded chemotherapy sessions at the National Cancer Institute. - Bernama
New Straits Times
2 hours ago
- New Straits Times
Malaysian tennis cries out for hero to inspire next generation
KUALA LUMPUR: Malaysian tennis is crying out for an icon. Without one, the next generation of players is at risk of falling into the same trap as those before them — full of promise, but ultimately going nowhere. Globally, tennis is the most prestigious and lucrative racquet sport. But in Malaysia, it sits far behind badminton, squash and even table tennis in terms of funding and attention from both the government and private sector. The reason? Results. Badminton has delivered Olympic medals, Thomas Cup wins and world champions like Aaron Chia-Soh Wooi Yik. Squash gave us the legendary Datuk Nicol David, an eight-time world champion. Even table tennis has seen Malaysian paddlers shine at the Asian Championships and Commonwealth Games. These sports have heroes — icons like the Sidek brothers, Datuk Lee Chong Wei and Nicol, who not only inspired a nation, but convinced parents that their kids could have a future in sport. Tennis, on the other hand, has no such figure. And when there's no funding, development suffers. We've never lacked talent. From Adam Jaya in the early 2000s to Christian Didier Chin and Ahmad Deedat Abdul Razak in more recent years, potential has always been there. But without sustained support, almost all have fallen by the wayside. Why? Because creating a world-class tennis player costs money. Serious money. You need top-level coaching, strength and conditioning, physiotherapy, nutrition and constant travel for tournaments to build experience and mental toughness. And with the ringgit struggling against major currencies, it's a steep uphill climb. What Malaysian tennis needs is a top-100 player. That's the magic number. Crack the top 100, and you're playing in Grand Slams and Masters events — the tournaments that matter, where sponsors and broadcasters pay attention. That exposure would be a game-changer. And Malaysia's best shot? The women's game. A towering height isn't a must. Italy's Jasmine Paolini, world No. 4 and just 1.63m tall, is living proof. Skill, fight and smart scheduling can get you there. Right now, we have two young hopefuls — Shihomi Leong (18) and Daania Hazli (15) — grinding it out on the ITF junior and futures circuits, mostly on their families' dime. Shihomi already has four singles and five doubles titles. Daania, playing in Europe, has made it to quarters and semis on clay and led Malaysia's junior Billie Jean King Cup squad to the final qualifying round in Kazakhstan last month. But they're on a tightrope. Like others before them, they risk running out of funds before making a breakthrough. This is where Tennis Malaysia (TM) must step up. TM has made strides with junior and national circuits, but support for players transitioning to the pro tour remains limited, largely due to funding issues, again stemming from the sport's lack of headline-grabbing results. But that's a cycle that can be broken with the right investment. Think of it as seed funding. If these players succeed, TM succeeds too. Sponsors will come. Government funding will follow. Look at track cycling. It barely had any support until Josiah Ng and later Azizulhasni Awang made headlines. The same can happen in tennis. One overlooked area is doubles, a quicker route to medals in multi-sport events. A pair like right-handed Shihomi and left-handed Daania could be formidable with the right backing. They should be touring together, with clay court tournaments high on the agenda. Clay suits smaller-framed players, builds endurance and is easier on the body. It also reduces the risk of early-career injuries caused by relentless play on hard courts. Medals at events, like the Asian Games, can bring instant recognition and funding. That's the power of results. While the women's path looks more promising, the men's game shouldn't be neglected. Take Mitsuki Leong, Shihomi's older brother. Last year, he became the first Malaysian to win an ITF title since V. Selvam in the 1990s, and he's now ranked a career-high No. 603 on the ATP Tour. That's progress. TM shouldn't view funding these players as a burden or a criticism. Instead, this is their moment. Led by president Mirzan Mahathir, the current TM executive council has a golden opportunity to reshape Malaysian tennis. To succeed where past leaderships have failed. To finally end the drought. Yes, it will take throwing the kitchen sink at the problem, but sports is a results game. No wins, no rewards. Our Southeast Asian neighbours have shown it's possible. Indonesia had Yayuk Basuki. Thailand had Paradorn Sri-chaphan. The Philippines now has rising star Alexandra Eala. It's time for Malaysia to stop waiting and start believing. The top 100 isn't a dream, it's a target. And hitting it could transform everything. * Fadhli Ishak is NST's senior sports journalist and a tennis lover
